Validated assay for personalised medicine

摘要

NextGen Science has entered into an agreement with Takeda Pharmaceutical Company to develop biomarker assays for use in Takeda's push towards personalised medicine.NextGen Sciences will develop validated protein biomarker assays which will be designed to target specific protein isofbrms found in liver and muscle in multiple species. They will be used in preclinical studies and validated for use in clinical studies.